
300 million child-friendly antimalarial treatments supplied without profit by Novartis
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…
Novartis announced the launch of Novartis Access in Kenya, the first country to benefit from…
Malaria experts from over 35 African countries came together recently at Novartis’s 14th annual National…